GlobeNewswire - Industry News on Medical Supplies

EssilorLuxottica : Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2021

2021-02-05T17:00:00Z

Disclosure of Share Capital and Voting Rights Outstanding
as of January 31, 2021

EssilorLuxottica : Nombre total de droits de vote et d��actions composant le capital social au 31 janvier 2021

2021-02-05T17:00:00Z

Nombre total de droits de vote et d��actions
composant le capital social au 31 janvier 2021

CooperCompanies Announces Release Date for First Quarter 2021

2021-02-04T21:15:00Z

SAN RAMON, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), today announced it will release first quarter 2021 financial results on Thursday, March 4, 2021, at 4:15 PM ET.?? Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.

ICU Medical, Inc. Announces Time of Fourth Quarter and Fiscal Year 2020 Earnings Conference Call

2021-02-04T13:00:00Z

SAN CLEMENTE, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its fourth quarter and fiscal year 2020 earnings release and conference call.

EssilorLuxottica and CooperCompanies?Announce Joint Venture for Acquisition of SightGlass Vision

2021-02-03T21:20:00Z

CHARENTON-LE-PONT, France, and SAN RAMON, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) -- EssilorLuxottica and CooperCompanies, two of the world��s leading vision care companies, have entered into an agreement to create a 50/50 joint venture for the acquisition of SightGlass Vision, a U.S. based life sciences company focused on developing innovative spectacle lenses to reduce the progression of myopia in children.

EssilorLuxottica : EssilorLuxottica and CooperCompanies Announce Joint Venture for Acquisition of SightGlass Vision

2021-02-03T21:20:00Z

EssilorLuxottica and CooperCompanies
Announce Joint Venture for Acquisition of SightGlass Vision

EssilorLuxottica : EssilorLuxottica et CooperCompanies annoncent la cr��ation d��une joint-venture pour l��acquisition de SightGlass Vision

2021-02-03T21:20:00Z

EssilorLuxottica et CooperCompanies annoncent la cr��ation d��une joint-venture pour l��acquisition de SightGlass Vision

EssilorLuxottica : EssilorLuxottica e CooperCompanies annunciano la creazione di una joint venture per l'acquisizione di SightGlass Vision

2021-02-03T21:20:00Z

EssilorLuxottica e CooperCompanies annunciano la creazione di una joint venture per l'acquisizione di SightGlass Vision

Align Technology Announces Commercial Availability of Invisalign? G8 With New SmartForce? Aligner Activation Features Globally

2021-02-03T21:00:00Z

Latest evolution in SmartForce innovation improves treatment predictability for frequently treated case types

Latest evolution in SmartForce innovation improves treatment predictability for frequently treated case types

Align Technology Announces the iTero Element Plus Series Next Generation of Scanners and Imaging Systems

2021-02-03T21:00:00Z

A series of new solutions feature advanced technology and capabilities designed to improve the scanning experience, increase practice productivity, and drive higher patient treatment conversion

A series of new solutions feature advanced technology and capabilities designed to improve the scanning experience, increase practice productivity, and drive higher patient treatment conversion

Align Technology Announces Record Fourth Quarter and Fiscal 2020 Financial Results

2021-02-03T21:00:00Z

Achieves 2 Millionth Invisalign Patient Milestone in EMEA

Achieves 2 Millionth Invisalign Patient Milestone in EMEA

Health Professional Resources Launches High-Performance Personal Protective Equipment (PPE) Line in Strategic Partnership with MAS Holdings

2021-02-03T14:00:00Z

U.S.-based health care wholesaler backed by leading global manufacturer behind Nike to bring essential PPE supplies to small and mid-sized businesses.

U.S.-based health care wholesaler backed by leading global manufacturer behind Nike to bring essential PPE supplies to small and mid-sized businesses.

eSight Receives Key Patents for Augmenting Sight Related to its Enhanced Vision Platform

2021-02-03T13:00:00Z

Patents affirm the continued innovation and commitment to improving quality of life for individuals with low vision and legal blindness

Patents affirm the continued innovation and commitment to improving quality of life for individuals with low vision and legal blindness

Coloplast delivers a good start to the year with 5% organic growth in Q1 and maintains its financial guidance for 2020/21

2021-02-02T11:01:55Z

Coloplast delivered 5% organic growth, and EBIT increased by 4% to DKK 1,536m, corresponding to an EBIT margin of 32%, in the first quarter of the 2020/21 financial year. The company maintains its financial guidance for 2020/21.

Coloplast leverer en god start p? ?ret med 5% organisk v?kst i f?rste kvartal og fastholder forventningerne til 2020/21

2021-02-02T11:01:55Z

Coloplast leverede 5% organisk v?kst, og driftsresultatet steg 4% til 1.536?mio.?kr., svarende til en overskudsgrad p? 32%, i f?rste kvartal af regnskabs?ret 2020/21. Virksomheden fastholder sine finansielle forventninger til 2020/21.

Coloplast A/S - Announcement no. 01/2021 �C Interim Financial Report, Q1 2020/21

2021-02-02T11:00:43Z

Q1 2020/21
Interim financial results, Q1 2020/21
(1 October 2020 - 31 December 2020)

Coloplast A/S - Selskabsmeddelelse nr. 01/2021 - Regnskabsmeddelelse, Q1 2020/21

2021-02-02T11:00:43Z

Q1 2020/21
Regnskabsmeddelelse, 1. kvartal 2020/21
(1. oktober 2020 �C 31. december 2020)

Cancer Genetics?Announces Closing of $10.0 Million Private Placement Priced At-the-Market

2021-02-01T22:16:27Z

RUTHERFORD, N.J., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the ��Company��) (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today announced the closing of its previously announced private placement of approximately $10.0 million through the issuance of an aggregate 2,758,624 shares of its common stock and warrants to purchase up to an aggregate 2,758,624 shares of common stock, at a combined purchase price of $3.625 per share of common stock and associated warrant in a private placement priced at-the-market under Nasdaq rules.

OraSure Subsidiary DNA Genotek��s OMNIgene?��ORAL Included in EUA Granted to Ambry Genetics for Use in COVID-19 RT-PCR Saliva Test

2021-01-29T11:00:00Z

This is the Eighth EUA to Include a Self-Collection Device from DNA Genotek

This is the Eighth EUA to Include a Self-Collection Device from DNA Genotek

Globus Medical Schedules Fourth Quarter and Full Year 2020 Earnings Release and Conference Call

2021-01-28T21:30:00Z

AUDUBON, Pa., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year ended December 31, 2020 after the market close on Wednesday, February 17,?2021. A copy of the release will be available on the Globus Medical website at www.globusmedical.com/investors.